JW Therapeutics: JW Therapeutics Co. Ltd Reports Earnings Results for the Full Year Ended December 31, 2024

JW (Cayman) Therapeutics Co. Ltd reported earnings results for the full year ended December 31, 2024. For the full year, the company reported sales was CNY 158.22 million compared to CNY 173.86 million a year ago. Net loss was CNY 590.62 million compared to CNY 768 million a year ago. Basic loss per share from continuing operations was CNY 1.43 compared to CNY 1.87 a year ago. Diluted loss per share from continuing operations was CNY 1.43 compared to CNY 1.87 a year ago. JW (Cayman) Therapeutics Co. Ltd reported earnings results for the full year ended December 31, 2024. For the full year, the company reported sales was CNY 158.22 million compared to CNY 173.86 million a year ago. Net loss was CNY 590.62 million compared to CNY 768 million a year ago. Basic loss per share from continuing operations was CNY 1.43 compared to CNY 1.87 a year ago. Diluted loss per share from continuing operations was CNY 1.43 compared to CNY 1.87 a year ago.